Novo Nordisk outlines plan for five multi-blockbusters by decade end

Novo Nordisk plans to launch at least five new "multi-blockbusters" by the end of the decade as part of an ambitious effort to support growth and offset slowing sales. Wall Street wasn't buying it. The Danish drugmaker, which shortened its brand name to Novo last week, outlined the plan in a statement that was left incomplete in the source text.